Skip to main content
BLLN
NASDAQ Industrial Applications And Services

BillionToOne Q2 revenue jumps 64%, swings to profit, but material weaknesses persist

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Diagnostics & Research Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$113.35
Mkt Cap
$6.898B
52W Low
$61.96
52W High
$150.44
52W Position info
83% above low
Off High info
25% below high
Rel. Volume info
1.2× avg
Market data snapshot near publication time

BLLN sits 83% above its 52-week low of $61.96.

Summary

BillionToOne posted Q2 2026 revenue of $109.4M, a 64% year-over-year increase, and swung to net income of $8.1M from a loss. Gross margin improved to 70%. Material weaknesses in internal controls remain unremediated, and a patent lawsuit from Illumina was disclosed.


Key Events · Earnings and Guidance · BLLN

  • Revenue Surges 64%

    Driven by a 35% increase in test volume and a 21% rise in average selling price, Q2 2026 revenue reached $109.4M.

  • Swings to Profitability

    Net income came in at $8.1M, or $0.15 per diluted share, a sharp turnaround from the net loss of $0.2M in Q2 2025.

  • Gross Margin Expands

    Reflecting higher average selling prices and operational efficiencies, gross margin improved to 70% from 65% a year ago.

  • Material Weaknesses Unremediated

    As of June 30, 2026, previously reported material weaknesses in internal control over financial reporting remain unremediated.


Analysis · BLLN · Industrial Applications And Services

A standout quarter saw revenue climb 64% to $109.4M and net income reach $8.1M, reversing a loss from the prior year. Gross margins expanded to 70%, underscoring operational leverage. Yet the company still carries unremediated material weaknesses in internal controls, and Illumina launched a patent lawsuit in May. While the balance sheet remains robust with $548.6M in cash, the control deficiencies and litigation present notable risks.

How filings like this one have moved

In the 30 days to Nov 17, 2026, 48.3% of the 2133 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.28%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, BLLN was trading at $113.35 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $6.9B. The 52-week trading range was $61.96 to $150.44. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

BLLN - Latest Insights

BLLN
Nov 18, 2026, 9:38 AM EST
Source: Seeking Alpha
Importance Score:
8
Price at Filing: $87.83
Real-time Price: $89.40 info
Change: +$1.57 (+2%) info
Market Cap: $4.235B info
BLLN
Nov 04, 2026, 4:47 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $113.00
Real-time Price: $89.40 info
Change: -$23.60 (-21%) info
Market Cap: $4.235B info
BLLN
Nov 04, 2026, 4:05 PM EST
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $119.49
Real-time Price: $89.40 info
Change: -$30.09 (-25%) info
Market Cap: $4.235B info
BLLN
Oct 07, 2026, 7:00 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $99.87
Real-time Price: $89.40 info
Change: -$10.47 (-10%) info
Market Cap: $4.235B info
BLLN
Aug 05, 2026, 4:25 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $106.38
Real-time Price: $89.40 info
Change: -$16.98 (-16%) info
Market Cap: $4.235B info